News and Press Releases
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development 24 April 2025 -- Cambridge, UK -- CN Bio,...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 24, 2025
Landmark BioVentures and G.CLIPS Biotech forge strategic alliance to address critical gaps in drug target engagement
Partnership brings into sharper focus need to integrate target engagement and candidate profiling solutions to optimize drug development process and increase likelihood of success23 April 2025 -- Basel, Switzerland, and...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2025
Labor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) Partner to Deploy GTC Comprehensive Suite of Tissue and Liquid Biopsy Testing for Solid Tumor and Hematologic Neoplasms in Germany
18 March 2025 -- Cologne, Germany and California, US -- Labor Dr. Wisplinghoff, one of Germany's largest and most renowned medical laboratories, and Genomic Testing Cooperative (GTC), the global leader in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 18, 2025
Novel Findings Using the Parsortix System Demonstrating Role of CTC:B Cell Clusters in Driving Cancer Progression
Findings may enable the development of novel drugs to target B cell and CTC cluster interactions to suppress cancer metastasis This pivotal work is likely to stimulate further interest in...
Category: Drug Discovery, Other, Pharmaceutical
Posted: February 6, 2025
NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform
Findings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single blood sample ANGLE invited to present data at EACR-Illumina webinar on 6 February...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 29, 2025
Clinical Trial Powered by Parsortix System Provides First-in-Class Data for Novel Approach to Cancer Treatment
Parsortix system used to identify patients with highly metastatic CTC clusters for targeted treatment New treatment strategy provides ‘uncharted opportunity’ to target metastasis responsible for the vast majority of cancer...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: January 24, 2025
DNA analysis of Parsortix-enriched CTCs and ctDNA provides complementary information in NSCLC patients treated with AstraZeneca’s osimertinib
The addition of CTC-DNA analysis to clinical trials could identify patients developing treatment resistance prior to disease progression CTC analysis identifies druggable targets which could be used to inform combined...
Category: Biotechnology, Clinical Trials
Posted: November 11, 2024
Publication Demonstrates Potential for Multi-Marker CTC Profiling in Early Prostate Cancer
Parsortix enriched CTCs detected at high rates in localised disease Multi-marker profiling of CTCs could support development of targeted therapies and help stratify patients in clinical trials 17 October 2024...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024
PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS
Leading life sciences technology companies to simplify clinical research activities and improve operational processes with integrated software solution 3 October 2024 -- Nottingham, UK and California, US -- PHARMASEAL specializes...
Category: Clinical Trials, Drug Discovery, Logistics
Posted: October 3, 2024
Ingenuity Centre, Nottingham University Innovation Park Triumph Road, Nottingham, NG7 2TU, United Kingdom
AGREEMENT WITH RECURSION PHARMACEUTICALS
New pharma agreement for Parsortix CTC analysis 19 September 2024 -- Guilford, UK -- ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: September 19, 2024
Abacus Medicine Pharma Services and Mirum Pharmaceuticals Sign Partnership Agreement for the Commercialization of Livmarli in the Nordics
10 September 2024 -- Copenhagen, Denmark -- Abacus Medicine Pharma Services (‘Abacus’) announces the signing of a partnership agreement with Mirum Pharmaceuticals, Inc. (‘Mirum’) for the commercialization of LIVMARLI® (maralixibat)...
Category: Drug Delivery, Other, Pharmaceutical
Posted: September 10, 2024
Kalvebod Brygge 35 1560 Copenhagen V Denmark
Data Supporting FDA Approval Published in High-Impact Journal
Publication of results from ANGLE’s Parsortix PC1 system validates use of Parsortix System for CTC isolation and harvest in metastatic breast cancer 22 August 2024 -- Guilford, UK -- ANGLE...
Category: Biotechnology, Other, Pharmaceutical
Posted: August 22, 2024
SSI Strategy and Metalmind Partner for Enterprise AI Solutions
23 July 2024 , New Jersey US, Kista, Sweden, – SSI Strategy LLC, a global leader in strategic consulting for life sciences, is pleased to announce a partnership with MPS...
Category: Biotechnology
Posted: July 30, 2024
Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
Just – Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term...
Category: BioManufacturing, Biotechnology
Posted: July 10, 2024
Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US
ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network
13 March 2024 -- Leiden, the Netherlands -- ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, today announced a partnership with Ginkgo Bioworks, which...
Category: Biotechnology
Posted: March 13, 2024
